{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:33:58Z","timestamp":1769844838882,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.spinee.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T05:08:15Z","timestamp":1309928895000},"page":"500-505","source":"Crossref","is-referenced-by-count":53,"title":["Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system"],"prefix":"10.1016","volume":"11","author":[{"given":"Anton E.","family":"Dmitriev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Ronald A.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviva J.","family":"Symes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2011.05.002_bib1","unstructured":"FDA: InFUSE\u2122 bone graft\/LT-CAGE\u2122 lumbar tapered fusion device\u2014P000058. FDA Approval Letter, 2002. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cftopic\/pma\/pma.cfm?num=P000058."},{"key":"10.1016\/j.spinee.2011.05.002_bib2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/BRS.0b013e318074c366","article-title":"The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers","volume":"32","author":"Glassman","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.spinee.2006.06.381","article-title":"Posterolateral lumbar spine fusion with INFUSE bone graft","volume":"7","author":"Glassman","year":"2007","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2011.05.002_bib4","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/BRS.0b013e3181ecf6e4","article-title":"Off-label use of bone morphogenetic proteins in the United States using administrative data","volume":"35","author":"Ong","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/BRS.0b013e3181e030e0","article-title":"Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2","volume":"36","author":"Knox","year":"2011","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.spinee.2010.06.020","article-title":"Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion","volume":"10","author":"Muchow","year":"2010","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2011.05.002_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3171\/2009.4.SPINE0876","article-title":"Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion","volume":"12","author":"Chen","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1227\/01.NEU.0000369517.21018.F2","article-title":"Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions","volume":"66","author":"Garrett","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spinee.2011.05.002_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00007632-199904150-00004","article-title":"Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog","volume":"24","author":"Meyer","year":"1999","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00007632-199906150-00002","article-title":"Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2\/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate","volume":"24","author":"Boden","year":"1999","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib11","first-page":"179","article-title":"Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety","volume":"12","author":"Martin","year":"1999","journal-title":"J Spinal Disord"},{"key":"10.1016\/j.spinee.2011.05.002_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.BRS.0000048644.91330.14","article-title":"Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion","volume":"28","author":"Akamaru","year":"2003","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib13","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/01.brs.0000160997.91502.3b","article-title":"Comparison of Healos\/bone marrow to INFUSE(rhBMP-2\/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion","volume":"30","author":"Kraiwattanapong","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.brs.0000162623.48058.8c","article-title":"Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates","volume":"30","author":"Barnes","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.spinee.2006.06.397","article-title":"rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin","volume":"7","author":"Singh","year":"2007","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2011.05.002_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2106\/00004623-200404000-00013","article-title":"Recombinant human bone morphogenetic protein-2 enhances anterior spinal fusion in a thoracoscopically instrumented animal model","volume":"86","author":"Sucato","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2011.05.002_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","article-title":"Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion","volume":"31","author":"Shields","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2011.05.002_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/BRS.0b013e3181a2da08","article-title":"Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis","volume":"34","author":"Crawford","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib20","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/BRS.0b013e31815b7596","article-title":"Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis","volume":"32","author":"Joseph","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00024720-200210000-00001","article-title":"Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages","volume":"15","author":"Burkus","year":"2002","journal-title":"J\u00a0Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2011.05.002_bib22","unstructured":"FDA: Executive summary for P050036 medtronic's AMPLIFY\u2122 rhBMP-2 matrix orthopaedic and rehabilitation devices advisory panel. 2010. Available at: http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/medicaldevices\/medicaldevicesadvisorycommittee\/orthopaedicandrehabilitationdevicespanel\/ucm220079.pdf."},{"key":"10.1016\/j.spinee.2011.05.002_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.spinee.2009.10.003","article-title":"Bone morphogenetic protein-2 used in spinal fusion with spinal cord injury penetrates intrathecally and elicits a functional signaling cascade","volume":"10","author":"Dmitriev","year":"2010","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2011.05.002_bib24","unstructured":"Dmitriev AE, Farhang S, Lehman RA Jr., et\u00a0al. Alterations in the rat recovery from spinal cord injury when using recombinant human bone morphogenetic protein-2 for posterolateral arthrodesis. J Bone and Joint Surg Am. In press."},{"key":"10.1016\/j.spinee.2011.05.002_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0014-4886(03)00087-6","article-title":"The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury","volume":"182","author":"Jones","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.spinee.2011.05.002_bib26","doi-asserted-by":"crossref","first-page":"E1350","DOI":"10.1097\/BRS.0b013e3181e85756","article-title":"Cytokine-mediated inflammatory reaction following posterior cervical decompression and fusion associated with recombinant human bone morphogenetic protein-2: a case study","volume":"35","author":"Robin","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2011.05.002_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/neu.2009.1080","article-title":"Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury","volume":"27","author":"Kwon","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.spinee.2011.05.002_bib28","first-page":"35","article-title":"A topical mixture for preventing, abolishing, and treating autophagia and self-mutilation in laboratory rats","volume":"40","author":"Zhang","year":"2001","journal-title":"Contemp Top Lab Anim Sci"},{"key":"10.1016\/j.spinee.2011.05.002_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s002210000630","article-title":"Neuropathic pain in aged rats: behavioral responses and astrocytic activation","volume":"137","author":"Stuesse","year":"2001","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.spinee.2011.05.002_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol Pain"},{"key":"10.1016\/j.spinee.2011.05.002_bib31","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00586-009-1046-1","article-title":"The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis","volume":"18","author":"Rihn","year":"2009","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2011.05.002_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-211-72958-8_1","article-title":"The potential of electrical stimulation to promote functional recovery after peripheral nerve injury\u2014comparisons between rats and humans","volume":"100","author":"Gordon","year":"2007","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.spinee.2011.05.002_bib33","unstructured":"FDA: INFUSE\/MASTERGRAFT\u2122 posterolateral revision device\u2014H040004. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/H040004b.pdf."}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943011003238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943011003238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T17:50:21Z","timestamp":1543686621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943011003238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1529943011003238"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2011.05.002","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}